Skip to main content
SpringerLink
Log in

Role of Host Genetics in Lymphoma

  • Chapter
  • First Online:
Neoplastic Hematopathology

Part of the book series: Contemporary Hematology ((CH))

  • 2142 Accesses

Abstract/Scope of Chapter

This chapter covers the role of host genetic background in determining the risk of development of non-Hodgkin lymphoma (NHL) and summarizes the new developments on the relationship between the host genetic polymorphisms and clinical outcome in NHL. The technical aspects of identifying host genetic polymorphisms and potential clinical applications for risk stratification of NHL based on host genetic polymorphisms are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 229.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 299.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 299.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Willis T, Dyer M. The role of immunoglobulin translocations in the pathogenesis of B-cell malignancies. Blood 2000;96(3):808-22.

    PubMed  CAS  Google Scholar 

  2. Falini B, Mason D. Proteins encoded by genes involved in chromosomal alterations in lymphoma and leukemia: clinical value of their detection by immunocytochemistry. Blood 2002;99(2):409-26.

    Article  PubMed  CAS  Google Scholar 

  3. Boultwood J. Ataxia telangiectasia gene mutations in leukaemia and lymphoma. J Clin Pathol 2001;54(7):512-6.

    Article  PubMed  CAS  Google Scholar 

  4. Chatterjee N, Hartge P, Cerhan JR, et al. Risk of non-Hodgkin’s lymphoma and family history of lymphatic, hematologic, and other cancers. Cancer Epidemiol Biomarkers Prev 2004;13(9):1415-21.

    PubMed  Google Scholar 

  5. Wang SS, Slager SL, Brennan P, et al. Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph). Blood 2007;109(8):3479-88.

    Article  PubMed  CAS  Google Scholar 

  6. Monti S, Savage KJ, Kutok JL, et al. Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response. Blood 2005;105(5):1851-61.

    Article  PubMed  CAS  Google Scholar 

  7. Dave SS, Wright G, Tan B, et al. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N Engl J Med 2004;351(21):2159-69.

    Article  PubMed  CAS  Google Scholar 

  8. Salaverria I, Zettl A, Bea S, et al. Chromosomal alterations detected by comparative genomic hybridization in subgroups of gene expression-defined Burkitt’s lymphoma. Haematologica 2008;93(9):1327-34.

    Article  PubMed  Google Scholar 

  9. Coiffier B, Lepage E, Briere J, et al. CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma. N Engl J Med 2002;346(4):235.

    Article  PubMed  CAS  Google Scholar 

  10. Sachidanandam R, Weissman D, Schmidt SC, et al. A map of human genome sequence variation containing 1. 42 million single nucleotide polymorphisms. Nature 2001;409(6822):928-33.

    Article  PubMed  CAS  Google Scholar 

  11. International HapMAp Project. 2008. (Accessed 29/12/2008, at http://www.hapmap.org/.)

  12. Johnson GC, Esposito L, Barratt BJ, et al. Haplotype tagging for the identification of common disease genes. Nat Genet 2001;29(2):233-7.

    Article  PubMed  CAS  Google Scholar 

  13. Syvanen AC. Toward genome wide SNP genotyping. Nat Genet 2005;37:S5-10.

    Article  Google Scholar 

  14. Skibola CF, Curry JD, Nieters A. Genetic susceptibility to lymphoma. Haematologica 2007;92(7):960-9.

    Article  PubMed  CAS  Google Scholar 

  15. Rothman N, Skibola CF, Wang SS, et al. Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. Lancet Oncol 2006;7(1):27-38.

    Article  PubMed  CAS  Google Scholar 

  16. Lan Q, Zheng T, Rothman N, et al. Cytokine polymorphisms in the Th1/Th2 pathway and susceptibility to non-Hodgkin lymphoma. Blood 2006;107(10):4101-8.

    Article  PubMed  CAS  Google Scholar 

  17. Forrest MS, Skibola CF, Lightfoot TJ, et al. Polymorphisms in innate immunity genes and risk of non-Hodgkin lymphoma. Br J Haematol 2006;134(2):180-3.

    Article  PubMed  CAS  Google Scholar 

  18. Wang SS, Cerhan JR, Hartge P, et al. Common genetic variants in proinflammatory and other immunoregulatory genes and risk for non-Hodgkin lymphoma. Cancer Res 2006;66(19):9771-80.

    Article  PubMed  CAS  Google Scholar 

  19. Cerhan JR, Ansell SM, Fredericksen ZS, et al. Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma. Blood 2007;110(13):4455-63.

    Article  PubMed  CAS  Google Scholar 

  20. Novak AJ, Slager SL, Ziesmer SC, et al. Polymorphisms in the BLyS gene are associated with an increased risk of developing B-Cell non-Hodgkin lymphoma. Blood 2007;110(11):173a.

    Google Scholar 

  21. Cerhan JR, Liu-Mares W, Fredericksen ZS, et al. Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin’s lymphoma. Cancer Epidemiol Biomarkers Prev 2008;17(11):3161-9.

    Article  PubMed  CAS  Google Scholar 

  22. Ansell SM, Novak A, Yang Z-Z, et al. Genetic Variation in Genes That Regulate T-Cell Differentiation and Function Is Associated with An Increased Risk of Developing B-Cell Non- Hodgkin Lymphoma. Blood 2008;112(11):1288a-9.

    Google Scholar 

  23. Skibola CF, Nieters A, Bracci PM, et al. A functional TNFRSF5 gene variant is associated with risk of lymphoma. Blood 2008;111(8):4348-54.

    Article  PubMed  CAS  Google Scholar 

  24. Warzocha K, Ribeiro P, Bienvenu J, et al. Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin’s lymphoma outcome. Blood 1998;91(10):3574-81.

    PubMed  CAS  Google Scholar 

  25. Juszczynski P, Kalinka E, Bienvenu J, et al. Human leukocyte antigens class II and tumor necrosis factor genetic polymorphisms are independent predictors of non-Hodgkin lymphoma outcome. Blood 2002;100(8):3037-40.

    Article  PubMed  Google Scholar 

  26. Lech-Maranda E, Baseggio L, Bienvenu J, et al. Interleukin-10 gene promoter polymorphisms influence the clinical outcome of diffuse large B-cell lymphoma. Blood 2004;103(9):3529-34.

    Article  PubMed  CAS  Google Scholar 

  27. Lee JJ, Kim DH, Lee NY, et al. Interleukin-10 gene polymorphism influences the prognosis of T-cell non-Hodgkin lymphomas. Br J Haematol 2007;137(4):329-36.

    Article  PubMed  CAS  Google Scholar 

  28. Cerhan JR, Wang S, Maurer MJ, et al. Prognostic significance of host immune gene polymorphisms in follicular lymphoma survival. Blood 2007;109(12):5439-46.

    Article  PubMed  CAS  Google Scholar 

  29. Cerhan JR, Maurer MJ, Hartge P, et al. Polymorphisms in one-carbon metabolism genes and overall survival in diffuse large B-cell lymphoma (DLBCL). Blood 2007;110(11):469a.

    Google Scholar 

  30. Cerhan J, Natkunam Y, Morton L, et al. LMO2 protein expression, LMO2 germline genetic variation, and overall survival in diffuse large B-cell lymphoma (DLBCL). Ann Oncol 2008;19:107.

    Google Scholar 

  31. Habermann TM, Maurer MJ, Wang SS, et al. Host genetic variation in the cell cycle and NF-kappa B pathways and overall survival in mantle cell lymphoma. Blood 2007;110(11):472a-3.

    Google Scholar 

  32. Habermann TM, Wang SS, Maurer MJ, et al. Host immune gene polymorphisms in combination with clinical and demographic factors predict late survival in diffuse large B-cell lymphoma patients in the pre-rituximab era. Blood 2008;112(7):2694-702.

    Article  PubMed  CAS  Google Scholar 

  33. Wang SS, Maurer MJ, Morton LM, et al. Polymorphisms in DNA repair and one-carbon metabolism genes and overall survival in diffuse large B-cell lymphoma and follicular lymphoma. Leukemia 2008; Oct 2. [Epub ahead of print].

    Google Scholar 

  34. Watters JW, McLeod HL. Cancer pharmacogenomics: current and future applications. Biochim Biophys Acta 2003;1603(2):99-111.

    PubMed  CAS  Google Scholar 

  35. Weng WK, Levy R. Two immunoglobulin G fragment C receptor polymorphisms independently predict response to rituximab in patients with follicular lymphoma. J Clin Oncol 2003;21(21):3940-7.

    Article  PubMed  CAS  Google Scholar 

  36. Mitrovic Z, Aurer I, Radman I, Ajdukovic R, Sertic J, Labar B. FCgammaRIIIA and FCgammaRIIA polymorphisms are not associated with response to rituximab and CHOP in patients with diffuse large B-cell lymphoma. Haematologica 2007;92(7):998-9.

    Article  PubMed  CAS  Google Scholar 

  37. Paiva M, Marques H, Martins A, Ferreira P, Catarino R, Medeiros R. FcgammaRIIa polymorphism and clinical response to rituximab in non-Hodgkin lymphoma patients. Cancer Genet Cytogenet 2008;183(1):35-40.

    Article  PubMed  CAS  Google Scholar 

  38. Kim DH, Jung HD, Kim JG, et al. FCGR3A gene polymorphisms may correlate with response to frontline R-CHOP therapy for diffuse large B-cell lymphoma. Blood 2006;108(8):2720-5.

    Article  PubMed  CAS  Google Scholar 

  39. Racila E, Link BK, Weng WK, et al. A polymorphism in the complement component C1qA correlates with prolonged response following rituximab therapy of follicular lymphoma. Clin Cancer Res 2008;14(20):6697-703.

    Article  PubMed  CAS  Google Scholar 

  40. Wang SS, Cozen W, Cerhan JR, et al. Immune mechanisms in non-Hodgkin lymphoma: joint effects of the TNF G308A and IL10 T3575A polymorphisms with non-Hodgkin lymphoma risk factors. Cancer Res 2007;67(10):5042-54.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Anatomic Pathology and Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA

    Ahmet Dogan

Authors
  1. Ahmet Dogan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ahmet Dogan .

Editor information

Editors and Affiliations

  1. M.D. Anderson Cancer Center, The University of Texas, Holcombe Blvd. 1515 , Houston, 77030, U.S.A.

    Dan Jones

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Humana Press, a part of Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Dogan, A. (2010). Role of Host Genetics in Lymphoma. In: Jones, D. (eds) Neoplastic Hematopathology. Contemporary Hematology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-384-8_32

Download citation

  • DOI: https://doi.org/10.1007/978-1-60761-384-8_32

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-60761-383-1

  • Online ISBN: 978-1-60761-384-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation